Comorbidity

Patients with COPD plus a depression/anxiety disorder had poorer scores related to disease burden and health-related quality of life, according to data published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.

WEST PALM BEACH, Fla. — A higher comorbidity burden was linked to an increased rate of adverse events as well as early discontinuation among patients with MS who participated in phase 3 clinical trials of disease-modifying therapies, data show.

In this video, Aruna Padmanabhan, MD, discusses the management of side effects seen in patients receiving PI3K inhibitors for the treatment of PIK3CA-mutated breast cancer.

Having GERD, diabetes or osteoporosis in addition to COPD heightened the likelihood for exacerbations, ED visits and hospitalizations, according to results published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.

Older age but not high comorbidity burden was significantly associated with overall survival among patients with hepatocellular carcinoma, even those with early-stage disease, according to study results.

PHILADELPHIA — Heart failure with preserved ejection fraction may be misdiagnosed in patients with COPD due to symptoms/signs being misinterpreted as COPD, according to a presentation at the 2024 GOLD COPD International Conference.

Inpatient total knee arthroplasty for patients with a high comorbidity burden may not be cost-effective, as published results showed increased procedural costs were not met with increased hospital revenue in this patient population.

PHILADELPHIA — Performing spirometry in patients with COPD before lung cancer screening could help identify those who would benefit most from screening, according to a presentation at the 2024 GOLD COPD International Conference.

BOSTON — Among adults with COPD starting a new inhaled maintenance treatment, common characteristics included older age and having multiple comorbidities, according to a poster presented at the CHEST Annual Meeting.

Dementia has been reported to affect nearly 55 million people worldwide, a number that is expected to rise to 78 million in 2030 and 139 million in 2050.